Wenzhou Kangning Hospital (02120) announced that its issued share capital remained unchanged at 19,598,900 H shares as of 2 December 2025. According to the document, multiple repurchases for cancellation were conducted between 14 August and 2 December 2025 but have not yet been canceled. The most recent repurchase, on 2 December 2025, involved 3,300 shares at HKD 10.9 per share for a total cost of HKD 35,970.

The repurchase mandate dated 30 June 2025 authorized the repurchase of up to 1,959,890 shares. A total of 1,932,900 shares had been repurchased under this mandate as of 2 December 2025, representing approximately 2.67127% of the issued H shares at the time the mandate was granted. Despite these repurchases, the closing balance of issued shares did not change, remaining at 19,598,900 shares. The mandated moratorium on any new share issuance or transfer of treasury shares following the latest repurchase extends until 1 January 2026.